Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2020 653
2021 1019
2022 559
2023 297
2024 34

Text availability

Article attribute

Article type

Publication date

Search Results

2,302 results

Results by year

Filters applied: . Clear all
Page 1
Convalescent plasma and hyperimmune globulin therapy in COVID-19.
Cagdas D. Cagdas D. Expert Rev Clin Immunol. 2021 Apr;17(4):309-316. doi: 10.1080/1744666X.2021.1894927. Epub 2021 Mar 12. Expert Rev Clin Immunol. 2021. PMID: 33620014 Review.
Introduction: Severe acute respiratory syndrome causing coronavirus SARS-CoV-2 (coronavirus disease 2019 (COVID-19)) has recently resulted in the recent global pandemic. ...This review discusses the current knowledge on CP and HIG therapies used …
Introduction: Severe acute respiratory syndrome causing coronavirus SARS-CoV-2 (coronavirus disease 2019 (COVID- …
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
Majumder J, Minko T. Majumder J, et al. AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2. AAPS J. 2021. PMID: 33400058 Free PMC article. Review.
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide with millions of people at risk in a growing number of count …
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 ( …
Convalescent Plasma for Covid-19.
Joyner MJ, Pirofski LA. Joyner MJ, et al. N Engl J Med. 2022 Sep 8;387(10):955. doi: 10.1056/NEJMc2208338. N Engl J Med. 2022. PMID: 36069882 No abstract available.
Convalescent Plasma for Covid-19.
Paneth N. Paneth N. N Engl J Med. 2022 Sep 8;387(10):955. doi: 10.1056/NEJMc2208338. N Engl J Med. 2022. PMID: 36069883 No abstract available.
Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection.
Kumar NR, Karanam VC, Kumar S, Kumar SD. Kumar NR, et al. South Med J. 2023 May;116(5):427-433. doi: 10.14423/SMJ.0000000000001546. South Med J. 2023. PMID: 37137479 Free PMC article. Review.
We investigated the safety and efficacy of convalescent plasma in specifically late-stage (designated as after 2 weeks of hospital admission) severe COVID-19 infection. ...RESULTS: Eight ICU patients received plasma late in the course of COVI
We investigated the safety and efficacy of convalescent plasma in specifically late-stage (designated as after 2 weeks of hosp …
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.
Senefeld JW, Franchini M, Mengoli C, Cruciani M, Zani M, Gorman EK, Focosi D, Casadevall A, Joyner MJ. Senefeld JW, et al. JAMA Netw Open. 2023 Jan 3;6(1):e2250647. doi: 10.1001/jamanetworkopen.2022.50647. JAMA Netw Open. 2023. PMID: 36633846 Free PMC article.
Although neutralizing anti-spike monoclonal-antibody treatment has been widely used to treat COVID-19, evolutions of SARS-CoV-2 have been associated with monoclonal antibody-resistant SARS-CoV-2 variants and greater virulenc …
Although neutralizing anti-spike monoclonal-antibody treatment has been widely used to treat COVID-19, evolutions of SARS
A look-back at convalescent plasma to treat COVID-19.
Garraud O, Lacombe K, Tiberghien P. Garraud O, et al. Transfus Apher Sci. 2021 Feb;60(1):103063. doi: 10.1016/j.transci.2021.103063. Epub 2021 Jan 12. Transfus Apher Sci. 2021. PMID: 33478889 Free PMC article. Review. No abstract available.
Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective.
Kanj S, Al-Omari B. Kanj S, et al. Viruses. 2021 May 7;13(5):849. doi: 10.3390/v13050849. Viruses. 2021. PMID: 34066932 Free PMC article. Review.
The treatment spectrum primarily includes ventilation support augmented with repurposed drugs and/or convalescent plasma transfusion (CPT) from recovered COVID-19 patients. ...The findings indicate that CPT shows potential in reducing the severity and …
The treatment spectrum primarily includes ventilation support augmented with repurposed drugs and/or convalescent plasma trans …
Convalescent plasma for people with COVID-19: a living systematic review.
Iannizzi C, Chai KL, Piechotta V, Valk SJ, Kimber C, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Jindal A, Cryns N, Estcourt LJ, Kreuzberger N, Skoetz N. Iannizzi C, et al. Cochrane Database Syst Rev. 2023 Feb 1;2(2):CD013600. doi: 10.1002/14651858.CD013600.pub5. Cochrane Database Syst Rev. 2023. PMID: 36734509 Free PMC article. Updated. Review.
BACKGROUND: Convalescent plasma may reduce mortality in patients with viral respiratory diseases, and is being investigated as a potential therapy for coronavirus disease 2019 (COVID-19). ...SELECTION CRITERIA: We included randomised controlled trials …
BACKGROUND: Convalescent plasma may reduce mortality in patients with viral respiratory diseases, and is being investigated as …
Convalescent plasma for people with COVID-19: a living systematic review.
Iannizzi C, Chai KL, Piechotta V, Valk SJ, Kimber C, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Jindal A, Cryns N, Estcourt LJ, Kreuzberger N, Skoetz N. Iannizzi C, et al. Cochrane Database Syst Rev. 2023 May 10;5(5):CD013600. doi: 10.1002/14651858.CD013600.pub6. Cochrane Database Syst Rev. 2023. PMID: 37162745 Review.
BACKGROUND: Convalescent plasma may reduce mortality in patients with viral respiratory diseases, and is being investigated as a potential therapy for coronavirus disease 2019 (COVID-19). ...SELECTION CRITERIA: We included randomised controlled trials …
BACKGROUND: Convalescent plasma may reduce mortality in patients with viral respiratory diseases, and is being investigated as …
2,302 results